Descriptive comparison of clinical burden and health resources in myasthenia gravis patients over two time periods, indicating unmet needs.
To descriptively compare clinical burden, quality of life, comorbidities, and healthcare resource utilization (HRU) among U.S. myasthenia gravis (MG) patients enrolled in the MGFA Global MG Patient Registry (MGFAPR) across two time periods: before and after biologic availability.
No takes yet. Share an insight, caveat, or question.
Park et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: